Codevelopment of Two or More New Investigational Drugs for Use in Combination
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
June 14, 2013
May 6, 2020
6a704e0b-f05e-4e65-91b9-7d60ac493505
Related Documents
Abuse-Deterrent Opioids-Evaluation and Labeling
Guidance DocumentApril 2, 2015Center for Drug Evaluation and Research
Investigational New Drug Applications for Positron Emission Tomography (PET) Drugs
Guidance DocumentDecember 3, 2012Center for Drug Evaluation and Research
Tablet Scoring:Nomenclature, Labeling, and Data for Evaluation
Guidance DocumentMarch 13, 2013Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox